.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Citi
Covington
Harvard Business School
Merck
Healthtrust
McKesson
Farmers Insurance
Queensland Health
Cipla

Generated: July 23, 2017

DrugPatentWatch Database Preview

Cinoxacin - Generic Drug Details

« Back to Dashboard

What are the generic sources for cinoxacin and what is the scope of cinoxacin freedom to operate?

Cinoxacin
is the generic ingredient in two branded drugs marketed by Teva and Lilly, and is included in three NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for cinoxacin.

Summary for Generic Name: cinoxacin

Tradenames:2
Patents:1
Applicants:2
NDAs:3
Drug Master File Entries: see list3
Bulk Api Vendors: see list36
Clinical Trials: see list1
Patent Applications: see list3,413
Drug Prices:see low prices
DailyMed Link:cinoxacin at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly
CINOBAC
cinoxacin
CAPSULE;ORAL018067-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Teva
CINOXACIN
cinoxacin
CAPSULE;ORAL073006-001Feb 28, 1992DISCNNoNo► Subscribe► Subscribe
Lilly
CINOBAC
cinoxacin
CAPSULE;ORAL018067-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Teva
CINOXACIN
cinoxacin
CAPSULE;ORAL073005-001Feb 28, 1992DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: cinoxacin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lilly
CINOBAC
cinoxacin
CAPSULE;ORAL018067-001Approved Prior to Jan 1, 19823,669,965► Subscribe
Lilly
CINOBAC
cinoxacin
CAPSULE;ORAL018067-002Approved Prior to Jan 1, 19823,669,965► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Boehringer Ingelheim
Deloitte
Baxter
US Department of Justice
Novartis
Medtronic
AstraZeneca
McKesson
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot